HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 43, 32240-32253, October 27, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/43/32240    most recent M603106200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hiltunen, M. Articles by Tanzi, R. E. Search for Related Content PubMed PubMed Citation Articles by Hiltunen, M. Articles by Tanzi, R. E. Social Bookmarking                      What's this?

Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and A Secretion^*

Mikko Hiltunen¹, Alice Lu¹, Anne V. Thomas, Donna M. Romano, Minji Kim, Phill B. Jones^¶, Zhongcong Xie, Maria Z. Kounnas^||, Steven L. Wagner^||, Oksana Berezovska, Bradley T. Hyman, Giuseppina Tesco, Lars Bertram, and Rudolph E. Tanzi²

From the Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts 02129, the Alzheimer's Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, Massachusetts 02129, the ^¶Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, and ^||Torrey Pines Therapeutics, Inc., La Jolla, California 92037

Ubiquilin 1 (UBQLN1) is a ubiquitin-like protein, which has been shown to play a central role in regulating the proteasomal degradation of various proteins, including the presenilins. We recently reported that DNA variants in UBQLN1 increase the risk for Alzheimer disease, by influencing expression of this gene in brain. Here we present the first assessment of the effects of UBQLN1 on the metabolism of the amyloid precursor protein (APP). For this purpose, we employed RNA interference to down-regulate UBQLN1 in a variety of neuronal and non-neuronal cell lines. We demonstrate that down-regulation of UBQLN1 accelerates the maturation and intracellular trafficking of APP, while not interfering with -, -, or -secretase levels or activity. UBQLN1 knockdown increased the ratio of APP mature/immature, increased levels of full-length APP on the cell surface, and enhanced the secretion of sAPP (- and -forms). Moreover, UBQLN1 knockdown increased levels of secreted A40 and A42. Finally, employing a fluorescence resonance energy transfer-based assay, we show that UBQLN1 and APP come into close proximity in intact cells, independently of the presence of the presenilins. Collectively, our findings suggest that UBQLN1 may normally serve as a cytoplasmic "gatekeeper" that may control APP trafficking from intracellular compartments to the cell surface. These findings suggest that changes in UBQLN1 steady-state levels affect APP trafficking and processing, thereby influencing the generation of A.

Received for publication, March 31, 2006 , and in revised form, August 8, 2006.

^* This work was supported by the Extendicare Foundation and the Finnish Academy (to M. H.), National Institutes of Health (NIH) Grant 5 P01 AG015379-08 (to B. T. H.), NIA, NIH Grant 1R01 AG023667-01 (to L. B.), Mass Alzheimer's Disease Research Center pilot Grant 218683 (to O. B.), and a research fellowship from the Deutsche Forschungsgemeinschaft (Grant TH 1129/1-1 to A. V. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Both authors contributed equally to this work.

² To whom correspondence should be addressed: Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, and Harvard Medical School, 114 16th St. C3009, Charlestown, MA 02129-4404. Tel.: 617-726-6845; Fax: 617-724-1949; E-mail: tanzi{at}helix.mgh.harvard.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. S. Liang, T. Dunckley, T. G. Beach, A. Grover, D. Mastroeni, K. Ramsey, R. J. Caselli, W. A. Kukull, D. McKeel, J. C. Morris, et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set Physiol Genomics, April 21, 2008; 33(2): 240 - 256. [Abstract] [Full Text] [PDF]

				H.-S. Hoe, S. S. Minami, A. Makarova, J. Lee, B. T. Hyman, Y. Matsuoka, and G. W. Rebeck Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing J. Biol. Chem., March 7, 2008; 283(10): 6288 - 6299. [Abstract] [Full Text] [PDF]

				A. Ganguly, R.M. R. Feldman, and M. Guo ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila Hum. Mol. Genet., January 15, 2008; 17(2): 293 - 302. [Abstract] [Full Text] [PDF]

				A. Li, Z. Xie, Y. Dong, K. M. McKay, M. L. McKee, and R. E. Tanzi Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes Hum. Mol. Genet., November 1, 2007; 16(21): 2626 - 2639. [Abstract] [Full Text] [PDF]

				H. J. Huttunen, S. Y. Guenette, C. Peach, C. Greco, W. Xia, D. Y. Kim, C. Barren, R. E. Tanzi, and D. M. Kovacs HtrA2 Regulates beta-Amyloid Precursor Protein (APP) Metabolism through Endoplasmic Reticulum-associated Degradation J. Biol. Chem., September 21, 2007; 282(38): 28285 - 28295. [Abstract] [Full Text] [PDF]

				G. Chen, X. Wang, J. Yu, S. Varambally, J. Yu, D. G. Thomas, M.-Y. Lin, P. Vishnu, Z. Wang, R. Wang, et al. Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma Cancer Res., April 1, 2007; 67(7): 3461 - 3467. [Abstract] [Full Text] [PDF]